Every record from Janoshik · page 16
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042521 | Liraglutide | ERP | ERP-2601-P6802 | 2026-Q2 | 98.11 | 4.55 | 90.6 | Buyer-sourced | 3 | MARGINAL |
| AX-2026-042298 | AOD-9604 | HJ | HJ-2601-N2483 | 2026-Q2 | 99.02 | 5.14 | 96.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042294 | BPC-157 | HJ | HJ-2511-P2829 | 2026-Q2 | 99.70 | 3.77 | 91.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042206 | Retatrutide | Homopeptide | HOMO-2512-D1047 | 2026-Q2 | 99.47 | 4.30 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041591 | SS-31 (Elamipretide) | QSC | QSC-2605-E6873 | 2026-Q2 | 99.66 | 2.08 | 102.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043250 | BPC-157 | SGN | SGN-2512-H1950 | 2026-Q2 | 98.73 | 4.20 | 104.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042342 | BPC-157 | HJ | HJ-2511-U3414 | 2026-Q2 | 98.65 | 5.63 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041624 | BPC-157 | QSC | QSC-2511-N8732 | 2026-Q2 | 99.93 | 5.71 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042994 | TB-500 | KP | KP-2605-C4659 | 2026-Q2 | 99.51 | 5.56 | 100.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042971 | 5-Amino-1MQ | KP | KP-2511-W4792 | 2026-Q2 | 99.45 | 4.19 | 107.1 | Supplier-supplied | 2 | FAIL |
| AX-2026-042960 | Retatrutide | KP | KP-2604-N4308 | 2026-Q2 | 98.81 | 5.45 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042698 | Retatrutide | GGPeps | GGPE-2512-D9394 | 2026-Q2 | 98.58 | 3.35 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042519 | Liraglutide | ERP | ERP-2601-P6802 | 2026-Q2 | 98.88 | 4.41 | 95.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042087 | PT-141 (Bremelanotide) | TFC | TFC-2512-V7681 | 2026-Q2 | 99.25 | 3.16 | 102.8 | Supplier-supplied | 0 | PASS |
| AX-2026-041362 | Tirzepatide | WWB | WWB-2604-T3876 | 2026-Q2 | 99.93 | 4.40 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041212 | NAD+ | WWB | WWB-2601-V1583 | 2026-Q2 | 99.93 | 10.36 | 88.5 | Laboratory-retained | 1 | FAIL |
| AX-2026-042901 | Semax | MKM | MKM-2512-B2992 | 2026-Q2 | 99.03 | 7.24 | 99.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042339 | L-Glutathione (reduced) | HJ | HJ-2511-F3082 | 2026-Q2 | 99.59 | 7.52 | — | Laboratory-retained | 0 | PASS |
| AX-2026-043523 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2511-G7276 | 2026-Q2 | 98.21 | 4.31 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-043342 | TB-500 | CPC | CPC-2605-B2433 | 2026-Q2 | 98.77 | 5.86 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2026-043269 | Hexarelin | CPC | CPC-2511-F1491 | 2026-Q2 | 98.61 | 5.38 | 105.7 | Supplier-supplied | 2 | FAIL |
| AX-2026-043236 | Melanotan II | SGN | SGN-2602-L1809 | 2026-Q2 | 98.59 | 2.31 | 101.9 | Supplier-supplied | 0 | PASS |
| AX-2026-042931 | L-Glutathione (reduced) | MKM | MKM-2511-F2902 | 2026-Q2 | 99.29 | 8.88 | 100.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042471 | Semaglutide | SWB | SWB-2603-T5632 | 2026-Q2 | 98.53 | 6.58 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042984 | Desmopressin | KP | KP-2512-U5139 | 2026-Q2 | 99.09 | 2.79 | 93.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042032 | Gonadorelin | TFC | TFC-2511-E6450 | 2026-Q2 | 99.62 | 3.09 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041806 | Tirzepatide | FGP | FGP-2605-R1831 | 2026-Q2 | 97.65 | 6.22 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042968 | 5-Amino-1MQ | KP | KP-2511-W4792 | 2026-Q2 | 98.87 | 4.32 | 91.5 | Buyer-sourced | 2 | FAIL |
| AX-2026-041919 | PT-141 (Bremelanotide) | JEEP | JEEP-2603-G4602 | 2026-Q2 | 99.28 | 5.31 | 105.1 | Supplier-supplied | 0 | PASS |
| AX-2026-041533 | BPC-157 | QYB | QYB-2601-H6381 | 2026-Q2 | 99.70 | 3.29 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041498 | Kisspeptin-10 | QYB | QYB-2512-X5662 | 2026-Q2 | 99.93 | 3.83 | 88.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041267 | Semaglutide | WWB | WWB-2603-W2120 | 2026-Q2 | 99.84 | 4.07 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043169 | BPC-157 | GL Biochem | GLBI-2602-T8420 | 2026-Q2 | 98.25 | 4.71 | 92.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042864 | Retatrutide | GGPeps | GGPE-2601-C2423 | 2026-Q2 | 97.66 | 4.68 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042341 | BPC-157 | HJ | HJ-2511-U3414 | 2026-Q2 | 98.37 | 5.66 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2026-042959 | Retatrutide | KP | KP-2604-N4308 | 2026-Q2 | 98.55 | 4.88 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042912 | Gonadorelin | MKM | MKM-2604-A2596 | 2026-Q2 | 99.21 | 5.07 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042889 | Mazdutide | MKM | MKM-2511-N2838 | 2026-Q2 | 98.76 | 7.02 | 88.5 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042319 | Tirzepatide | HJ | HJ-2605-D3120 | 2026-Q2 | 98.32 | 4.95 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042620 | KPV | GGPeps | GGPE-2511-K8830 | 2026-Q2 | 98.40 | 4.83 | 95.9 | Supplier-supplied | 1 | FAIL |